fda compounding restrictions bpc-157 warning unapproved peptide safety FDA Targets GLP-1 and Peptide Compounding, Advertising and ' The FDA just put peptides
Description
Batch numbers are traceable and recorded.
Theyre wanting a certain amount of certitude that, frankly, is appropriate for most drugs, but not for this moment. Regulatory shortcuts exist that would allow the FDA to skip the more laborious approval process
Gut barrier integrity provides the critical link
doi:10.1054/ghir.2001.0232 3
